Drug(薬物リスト) DrugBank | All Description Patterns

e.g. "Sirolimus", "アダリムマブ"

ABCDEFGH I JKLMNOPQRSTUVWXYZother

28 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG
💬 Info on mouse-over
KEGG GENES
💬 Info on mouse-over
KEGG PATHWAY 指定難病告示番号
💬 Info on mouse-over
1 Active bmn 111: daily subcutaneous injection of 15 ug/kg of bmn 111 - - - - 1件: 276💬
2 Bgj398 (also known as bbp-831) - - - - 1件: 276💬
3 Bmn 111 - - - - 1件: 276💬
4 C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker Polyethylene glycol 1件: D03370💬 - - 1件: 276💬
5 Infigratinib Infigratinib 1件: D11589💬 3件: FGFR1, FGFR2, FGFR3💬 21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 1件: 276💬
6 Infigratinib 0.016 mg/kg Infigratinib 1件: D11589💬 3件: FGFR1, FGFR2, FGFR3💬 21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 1件: 276💬
7 Infigratinib 0.032 mg/kg Infigratinib 1件: D11589💬 3件: FGFR1, FGFR2, FGFR3💬 21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 1件: 276💬
8 Infigratinib 0.064 mg/kg Infigratinib 1件: D11589💬 3件: FGFR1, FGFR2, FGFR3💬 21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 1件: 276💬
9 Infigratinib 0.128 mg/kg Infigratinib 1件: D11589💬 3件: FGFR1, FGFR2, FGFR3💬 21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 1件: 276💬
10 Infigratinib phosphate Infigratinib 1件: D11589💬 3件: FGFR1, FGFR2, FGFR3💬 21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 1件: 276💬
11 Modified recombinant human c-type - - - - 1件: 276💬
12 Modified recombinant human c-type natriuretic peptide - - - - 1件: 276💬
13 Modified rhcnp - - - - 1件: 276💬
14 Natriuretic peptide - - - - 1件: 276💬
15 Normal saline - - - - 16件:  6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299💬
16 Pf-07256472 - - - - 1件: 276💬
17 Phosphate Phosphate ion - - - 30件:  2 ,  3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299💬
18 Placebo - - - - 26件:  3 ,  5 ,  6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276💬
19 Polyethylene glycol Polyethylene glycol 1件: D03370💬 - - 5件: 96, 97, 235, 276, 299💬
20 Recifercept - - - - 1件: 276💬
21 Recifercept (proposed inn) - - - - 1件: 276💬
22 Somatropin Somatotropin 1件: D02691💬 1件: GHR💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 16件:  2 ,  3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299💬
23 Ta-46 - - - - 1件: 276💬
24 Tbd - - - - 4件: 19, 86, 276, 299💬
25 Transcon cnp - - - - 1件: 276💬
26 Transcon cnp 3.9 mg cnp-38/vial - - - - 1件: 276💬
27 Vorsoritide - - - - 1件: 276💬
28 Vosoritide Vosoritide 1件: D11190💬 - - 1件: 276💬

先頭へ